胶原赛道竞争升级 全球首款牛跟腱胶原发布

Core Insights - The world's first collagen product derived from beef tendon will be launched by Yuansong on January 2, marking a significant development in the collagen market [1] - Yuansong Group has formed a strategic partnership with Chongshan Biotechnology to combine their technological advantages, aiming to shift the collagen field from "volume enhancement" to "nutritional tightening" [1] - The collagen market, currently valued at 200 billion, is projected to reach 500 billion by 2030, driven by applications in medical, beauty, and health sectors [1] Company Developments - Chongshan Biotechnology's "Jiaoyuan Angel," the first beef tendon collagen implant, received approval from the National Medical Products Administration on December 10 [1] - With the approval of Jiaoyuan Angel, the number of collagen products with Class III medical device certification in China has increased to 15, although only one-third of these products have become mainstream [1] - Chongshan's chairman highlighted that Jiaoyuan Angel stands out due to its redefined core dimensions in ingredient concentration, material source, and application technology [1] Industry Trends - The collaboration between Yuansong Group and Chongshan Biotechnology signifies an upgrade in the collaborative model between clinical institutions and research enterprises [1] - The new product is not just an addition but is intended to create a comprehensive treatment plan that integrates anti-aging medicine, natural aesthetics, and material science [1]